TSU-TSAIR CHI, Ph.D.

CHI

TSU-TSAIR CHI, Ph.D., born in China, came to the US and earned his Ph.D. in Biochemistry from the Waksman Institute of Microbiology at Rutgers State University, New Jersey in 1978. Since then, he has been involved in Infectious Disease work at E.R. Squibb and Sons, Inc. in New Jersey and Cancer Screening at Warner-Lambert/Parke-Davis Co. in Michigan. He was also the Laboratory Director at Omicron Incorporated in Redlands, California where he worked in the fields of cancer and atherosclerosis. In 1988, Dr. Chi developed a California state-licensed Neostop Anti-Tumor Vaccine for poultry. He has also received a patent for the detection of antibodies against a chronic gonadotropin-like substance.

Dr. Chi has published articles on his herbal formulas in Journals such as the “International Journal of Integrative Oncology” and “Townsend Letter for Doctors and Patients.” Some of his herbal formulas include Myomin, an aromatase reducer for estrogen-dominant conditions and Angiostop, a sea cucumber extract that blocks new blood vessel formation from tumors and induces cancer cell death by activating caspases. Additional clinical cancer research on Angiostop are published in the “International Journal of Cancer” and “Cancer Biology & Therapy.”

For over 30 years Dr. Chi has been the President of Chi’s Enterprise, Inc. located in Anaheim, California and he may be reached by phone 714-777-1542, fax 714-777-7186, e-mailpostmaster@chi-health.com and website www.chi-health.com.

He will speak on Angiostops For Cancer Management.

For DVD Ordering Information, Click Here To order

Return to Biographies & DVDs 2016


Return to Home Page.